BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22112290)

  • 1. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer.
    Jones LW; Hornsby WE; Goetzinger A; Forbes LM; Sherrard EL; Quist M; Lane AT; West M; Eves ND; Gradison M; Coan A; Herndon JE; Abernethy AP
    Lung Cancer; 2012 May; 76(2):248-52. PubMed ID: 22112290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which field walking test should be used to assess functional exercise capacity in lung cancer? An observational study.
    Granger CL; Denehy L; Parry SM; Martin J; Dimitriadis T; Sorohan M; Irving L
    BMC Pulm Med; 2015 Aug; 15():89. PubMed ID: 26264470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic validation of the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in inoperable non-small-cell lung cancer.
    Denehy L; Hornsby WE; Herndon JE; Thomas S; Ready NE; Granger CL; Valera L; Kenjale AA; Eves ND; Jones LW
    J Thorac Oncol; 2013 Dec; 8(12):1545-50. PubMed ID: 24389436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.
    Ruden E; Reardon DA; Coan AD; Herndon JE; Hornsby WE; West M; Fels DR; Desjardins A; Vredenburgh JJ; Waner E; Friedman AH; Friedman HS; Peters KB; Jones LW
    J Clin Oncol; 2011 Jul; 29(21):2918-23. PubMed ID: 21690470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal important difference of the 6-minute walk distance in lung cancer.
    Granger CL; Holland AE; Gordon IR; Denehy L
    Chron Respir Dis; 2015 May; 12(2):146-54. PubMed ID: 25749346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer.
    Jones LW; Watson D; Herndon JE; Eves ND; Haithcock BE; Loewen G; Kohman L
    Cancer; 2010 Oct; 116(20):4825-32. PubMed ID: 20597134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative exercise capacity in patients undergoing thoracoscopic lobectomy for non-small cell lung cancer.
    Hamada K; Irie M; Fujino Y; Hyodo M; Hanagiri T
    Lung Cancer; 2019 Feb; 128():47-52. PubMed ID: 30642452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the six-minute walk in advanced non-small cell lung cancer.
    Kasymjanova G; Correa JA; Kreisman H; Dajczman E; Pepe C; Dobson S; Lajeunesse L; Sharma R; Small D
    J Thorac Oncol; 2009 May; 4(5):602-7. PubMed ID: 19276833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
    Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise Training for Patients Pre- and Postsurgically Treated for Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.
    Ni HJ; Pudasaini B; Yuan XT; Li HF; Shi L; Yuan P
    Integr Cancer Ther; 2017 Mar; 16(1):63-73. PubMed ID: 27151583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure.
    Forman DE; Fleg JL; Kitzman DW; Brawner CA; Swank AM; McKelvie RS; Clare RM; Ellis SJ; Dunlap ME; Bittner V
    J Am Coll Cardiol; 2012 Dec; 60(25):2653-61. PubMed ID: 23177293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tai Chi Chuan in postsurgical non-small cell lung cancer patients: study protocol for a randomized controlled trial.
    Pan H; Pei Y; Li B; Wang Y; Liu J; Lin H
    Trials; 2018 Jan; 19(1):2. PubMed ID: 29301544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome.
    Kempny A; Dimopoulos K; Alonso-Gonzalez R; Alvarez-Barredo M; Tutarel O; Uebing A; Piatek P; Marino P; Swan L; Diller GP; Wort SJ; Gatzoulis MA
    Int J Cardiol; 2013 Oct; 168(5):4784-9. PubMed ID: 23962785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation.
    Jones LW; Devlin SM; Maloy MA; Wood WA; Tuohy S; Espiritu N; Aquino J; Kendig T; Michalski MG; Gyurkocza B; Schaffer WL; Ali B; Giralt S; Jakubowski AA
    Oncologist; 2015 Nov; 20(11):1290-7. PubMed ID: 26446235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of 6-Min Walk Test to Predict Postoperative Cardiopulmonary Complications in Patients With Non-small Cell Lung Cancer.
    Lee H; Kim HK; Kang D; Kong S; Lee JK; Lee G; Shin S; Cho J; Zo JI; Shim YM; Park HY
    Chest; 2020 Jun; 157(6):1665-1673. PubMed ID: 31987880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Result of the 6-min walk test is an independent prognostic factor of surgically treated non-small-cell lung cancer.
    Marjanski T; Badocha M; Wnuk D; Dziedzic R; Ostrowski M; Sawicka W; Rzyman W
    Interact Cardiovasc Thorac Surg; 2019 Mar; 28(3):368-374. PubMed ID: 30203070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of health-related quality of life and exercise capacity according to stages in patients with non-small cell lung cancer.
    Yılmaz E; Özalevli S; Ersöz H; Yeğin A; Önen A; Akkoçlu A
    Tuberk Toraks; 2013; 61(2):131-9. PubMed ID: 23875591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.